Eye (2016) 30, 770 © 2016 Macmillan Publishers Limited All rights reserved 0950-222X/16 www.nature.com/eye

CORRIGENDUM

Intravitreal fluocinolone acetonide (Iluvien) for treatment of refractory diabetic macular oedema in vitrectomised eyes

A Kumar, Q Alfahad, A Mitra, S Elsherbiny and PL Lip

Eye (2016) 30, 770; doi:10.1038/eye.2016.45

Conflict of interest AM is an Advisory Board Member of Alimera Sciences. The remaining authors declare no conflict of interest.

Correction to: Eye (2016) 30, 763–764; doi: 10.1038/eye.2015.281; published online 22 January 2016 Since the online publication of this article, it has been noted that the conflict of interest statement was incomplete. The complete statement can be found below:

The authors would like to apologise for this error. This error has now been rectified, and the corrected article appears in this issue. The html and online pdf versions have also been rectified, and now carry the corrected paper.

Intravitreal fluocinolone acetonide (Iluvien) for treatment of refractory diabetic macular oedema in vitrectomised eyes.

Intravitreal fluocinolone acetonide (Iluvien) for treatment of refractory diabetic macular oedema in vitrectomised eyes. - PDF Download Free
58KB Sizes 1 Downloads 13 Views

Recommend Documents